Innovative Medical Applications

Riordan Technologies’ network of companies have long been involved in cutting-edge technological advances within various scientific fields. We received the FDA’s first Compassionate Use IND for umbilical cord-derived mesenchymal stem cells to treat Duchenne’s Muscular Dystrophy. In both Panama and within the United States, we produce high-quality umbilical and placental-derived regenerative products, as well as maintain a high-quality line of unique and effective supplements. Across a broad range of regenerative medical applications, we will always strive to innovate.